Subscribe To
Cenovus energy: mixed opportunity looking ahead
Cenovus Energy: Mixed Opportunity Looking Ahead...
April 6, 2022, 4:51 am
Curis plummets to 52-week low after fda clinical hold on blood cancer trial
The FDA has placed a partial clinical hold on Curis Inc's (NASDAQ: CRIS) TakeAim Leukemia Phase 1/2a study in relapsed or refractory (R/R) acute m...
April 4, 2022, 9:10 am
Has cenovus energy (cve) outpaced other oils-energy stocks this year?
Here is how Cenovus Energy (CVE) and Helmerich & Payne (HP) have performed compared to their sector so ...
April 1, 2022, 11:07 am
Novartis (nvs) beovu gets label expansion for dme in eu
Novartis (NVS) ophthalmology drug Beovus label gets expanded in EU for diabetic macular edema....
April 1, 2022, 10:32 am
Here's why cenovus energy (cve) is a great momentum stock to buy
Does Cenovus Energy (CVE) have what it takes to be a top stock pick for momentum investors? Let's find ...
March 28, 2022, 1:33 pm
Astrazeneca (azn) gets eu nod for covid-19 antibody cocktail
The European Commission approves AstraZeneca's (AZN) Evusheld for the pre-exposure prophylaxis of COVID...
March 28, 2022, 1:33 pm
Astrazeneca's covid drug bags eu approval
AstraZeneca PLC (LSE:AZN) has received EU marketing authorisation for its Evusheld antibody combination...
March 28, 2022, 5:13 am
Roche to present data across broad and impactful neuroscience portfolio at 2022 aan annual meeting
Basel, 25 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data for its approved and investigational medicines across neurological ...
March 25, 2022, 2:00 am
Here is why bargain hunters would love fast-paced mover cenovus (cve)
Cenovus (CVE) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice...
March 22, 2022, 10:32 am
Astrazeneca's covid vaccine alternative gets uk green light
AstraZeneca PLC (LSE:AZN)'s preventative treatment for COVID-19 has been approved by the UK medical regulator, as an alternative for people for whom v...
March 17, 2022, 9:08 am
Astrazeneca's covid-19 drug application under review by eu regulators
AstraZeneca PLC (LSE:AZN)'s application for Evusheld, an antibody-based Coronavirus (COVID-19) therapy...
March 16, 2022, 7:47 am
Synovus offers an attractive mix of organic and macro growth
Synovus is well-placed to leverage growing commercial loan demand across multiple growth markets in the...
March 15, 2022, 2:59 pm
Cenovus energy: a stronghold with great shareholder prioritization
Cenovus Energy has had greater emphasis on shareholder returns through dividend doubling in Q4 2021, an...
March 15, 2022, 7:51 am
Corvus pharmaceuticals, inc. (crvs) ceo richard miller on q4 2021 results - earnings call transcript
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q4 2021 Results - Earnings Call Transcript...
March 10, 2022, 7:34 pm
Cenovus energy (cve): strong industry, solid earnings estimate revisions
Cenovus Energy (CVE) has seen solid earnings estimate revision activity over the past month, and belong...
March 10, 2022, 10:32 am
Synovus (snv) rewards shareholders with 3% dividend hike
Synovus (SNV) announces a 3% sequential hike in its quarterly cash dividend. Should you consider holdin...
March 7, 2022, 6:46 pm
Is cenovus energy (cve) outperforming other oils-energy stocks this year?
Here is how Cenovus Energy (CVE) and Black Stone Minerals (BSM) have performed compared to their sector...
February 28, 2022, 10:45 am
Is cenovus energy (cve) outperforming other oils-energy stocks this year?
Here is how Cenovus Energy (CVE) and Black Stone Minerals (BSM) have performed compared to their sector...
February 28, 2022, 10:45 am
Is cenovus energy (cve) outperforming other oils-energy stocks this year?
Here is how Cenovus Energy (CVE) and Black Stone Minerals (BSM) have performed compared to their sector...
February 28, 2022, 10:45 am
Synovus' (snv) organic growth profile aids, rising costs ail
Despite bearing a concentrated loan portfolio, Synovus (SNV) is worth holding on to in your portfolio o...
February 16, 2022, 5:45 pm